TCR2 Therapeutics
-$0.05 (-0.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell TCRR and other stocks, options, and ETFs commission-free!
About TCRR
TCR2 Therapeutics Inc. Common Stock, also called TCR2 Therapeutics, is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy.
CEO
Garry E. Menzel
Employees
118
Headquarters
Cambridge, Massachusetts
Founded
2015
TCRR Key Statistics
Market Cap
795.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
304.91K
High Today
$19.85
Low Today
$18.70
Open Price
$18.90
Volume
215.85K
52 Week High
$35.86
52 Week Low
$8.71
Analyst Ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
TCRR Earnings
-$0.67
-$0.45
-$0.22
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market